Evidence map›Paper›PMID 41816349›Full record

ReviewFrontiers in immunology2026

Regulatory T cells in hypoxic environments.

Lourdes González-Rivera, Rodrigo Luna-Gutiérrez, Stephanie Cárdenas, Consuelo Merino-González, Alex Handy, Inés Pepper, Mercedes Natalia López

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lourdes González-RiveraFacultad de Medicina, Instituto de Ciencias Biomédicas (ICBM), Universidad de Chile, Núcleo Interdisciplinario de Farmacología e Inmunología, Santiago, Chile.
Rodrigo Luna-GutiérrezInstituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Núcleo Interdisciplinario de Fisiología, Biofísica y Fisiopatología, Santiago, Chile.
Stephanie CárdenasFacultad de Medicina, Instituto de Ciencias Biomédicas (ICBM), Universidad de Chile, Núcleo Interdisciplinario de Farmacología e Inmunología, Santiago, Chile.
Consuelo Merino-GonzálezFacultad de Medicina, Instituto de Ciencias Biomédicas (ICBM), Universidad de Chile, Núcleo Interdisciplinario de Farmacología e Inmunología, Santiago, Chile.
Alex HandyFacultad de Medicina, Instituto de Ciencias Biomédicas (ICBM), Universidad de Chile, Núcleo Interdisciplinario de Farmacología e Inmunología, Santiago, Chile.
Inés PepperFaculty of Medicine, Universidad de Chile, Santiago, Chile.
Mercedes Natalia LópezFacultad de Medicina, Instituto de Ciencias Biomédicas (ICBM), Universidad de Chile, Núcleo Interdisciplinario de Farmacología e Inmunología, Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxygen availability is considered as an important determinant of immune regulation, yet its impact on regulatory T cells remains incompletely understood. In this review, we synthesize current evidence on how chronic and intermittent hypoxia influence the differentiation, stability and function of regulatory T cells across diverse physiological and pathological settings. We describe the main cellular pathways engaged during hypoxic adaptation, with emphasis on the role of hypoxia-inducible factors in shaping regulatory T cell metabolism and lineage integrity. We then evaluate findings from clinical contexts characterized by sustained or cyclical oxygen deprivation, including chronic lung disease, sleep-disordered breathing and severe viral infection. Across these conditions, hypoxia is associated with alterations in regulatory T cell phenotype and its suppressive function, although patterns vary according to microenvironment and disease stage. A clearer understanding of how distinct hypoxic patterns modulate regulatory T cell biology will be essential for identifying therapeutic strategies aimed at restoring immune balance in hypoxia-associated disease.

Indexed as

HypoxiaT-Lymphocytes, RegulatoryAnimalsCOVID-19HumansSARS-CoV-2chronic obstructive pulmonary diseaseCOVID-19hypoxiahypoxia-Inducible factor 1, alpha Subunitinflammatory mediatorsmetabolic reprogrammingobstructive sleep apnearegulatory T (Treg) cell

Identifiers

PMID41816349
PMCPMC12971656

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.